Skip to content

Apotheek Mieke Dons

Active
Private limited companyfounded 2012active for 14 yearsMonnikenhofstraat 179, 2040 Antwerpen, BelgiumKBO/BCE: BE 0846.148.618

From the official registers: KBO 13 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

Apotheek Mieke Dons has been active since 2012 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €981,325 and a net result of €199,827. Equity is growing by about 27% per year across the filed financial years. Its solvency ranks better than 90% of 12,737 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Risk analysisFollow ReportCompare
Apotheek Mieke DonsActiveChecked score 98/100
Risk analysis ReportCompare

Overview

Official details

KBO
Status
Active since 21-05-2012 Normal situation
Legal form
Private limited company
Registered office
Monnikenhofstraat 179, 2040 Antwerpen
Activity
Retail sale of pharmaceutical products NACE 47730
Establishment unit
2.209.766.995 2040 Antwerpen, since 05-06-2012
Financial year end
30 September
Peppol
Reachable since 11-06-2025
Company details

Who decides

Board
Shareholders
Board & ownership

How it is doing

98 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts to 30-09-2025
Gross margin
€309,423
▲ 4.6%
Turnover
≈ €1.1m
estimated
Profit
€199,827
▲ 18.3%
Equity
€981,325
▲ 25.6%
Total assets
€1.2m
▲ 17.7%
2025 accounts 21 days early
Filed on 09-04-2026PDF
Financials
Why 98raises riskSector: Retail trade (NACE 47)lowers riskLiquidity: current ratio 6.66, cash €722,473Equity €981,325 (81.4% of total assets)Figures for financial year 2025 (filed 09-04-2026)Show the evidence

Checked score

Score 2025
98 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 87% of its sector peers (NACE 47, micro)
Every signal that counts is listed under Signals.
Financial strength · tick = 2024
Strong
Solvency 100=
equity 81.4% of total assets
Liquidity 98+3
short-term debt 13.9% · cash 59.9%
Profitability 89=
return on assets 16.6%
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,270 companies, NACE 47, micro)
Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026highest value 05-2026: < 0.1%● unchanged vs 04-2026lowest value 06-2026: < 0.1%● unchanged vs 05-2026lowest value 07-2026: < 0.1%● unchanged vs 06-2026lowest value 08-2026: < 0.1%● unchanged vs 07-2026lowest value 09-2026: < 0.1%● unchanged vs 08-2026lowest value 10-2026: < 0.1%● unchanged vs 09-2026
Credit of up to €95,000 on 30-day terms is acceptable
Liquidity ample (current ratio 6.66, compared with 5.02 in 2024, above the usual 1.5; short-term debt: 13.9% and cash: 59.9% of total assets), and 18.6% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 92% on solvency, 96% on liquidity, 84% on profitability and 77% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Liquidity: current ratio 6.66, cash €722,473
NBB · annual accounts
lowers risk · Equity €981,325 (81.4% of total assets)
NBB · annual accounts
raises risk · Sector: Retail trade (NACE 47)
KBO
lowers risk · Figures for financial year 2025 (filed 09-04-2026)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 30-09-2025 was due by 30-04-2026 and was filed on 09-04-2026, 21 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
21 days early
2024
7 days early
2023
141 days early
2022
26 days early
2021
60 days early
2020
59 days early
2019
31 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 49 days before the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The financial year that closed on 30-09-2026 is due by 30-04-2027. Nothing is late today. The company usually files around 4 April (4 of the last 5 filed years within 34 days of that day).
Companies Code · seven months
Where today falls in the filing period
30-09-2026 year end01-11-2026 today30-04-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage

Key points

  • Positive: Among the best 10% on solvencysector median 36.6% · 12,737 companies 81.4% View
  • Positive: Filed on time since financial year 2018accounts within the deadline every year 8 years View
  • Positive: 7 profitable years in a rowprofit 2025: €199,827 7 years View
  • Positive: Equity rose in 2025from €781,498 to €981,325 ▲ 25.6% View

Documents

Annual accounts at the NBB

All 13 annual accounts

Acts in the Belgian Official Gazette

All publications in the Belgian Official Gazette

Articles and registers

Key facts about Apotheek Mieke Dons

What is the company number of Apotheek Mieke Dons?
0846.148.618. In Belgium the VAT number is the company number with BE in front: BE 0846.148.618.
Where is Apotheek Mieke Dons based?
The registered office is at Monnikenhofstraat 179, 2040 Antwerpen.Company details
What does Apotheek Mieke Dons do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of Apotheek Mieke Dons?
Private limited company (BV).
When was Apotheek Mieke Dons founded?
On 21-05-2012.
Is Apotheek Mieke Dons still active?
Yes, Apotheek Mieke Dons is an active enterprise in the KBO register.
What is the turnover of Apotheek Mieke Dons?
≈ €1.1m in financial year 2025. Estimated from the gross margin of €309,423: probably between €870,000 and €1.9m, based on 47 comparable companies, NACE 477.Financials
Is Apotheek Mieke Dons profitable?
In financial year 2025, Apotheek Mieke Dons made a profit of €199,827.
Where can I find the annual accounts of Apotheek Mieke Dons?
Apotheek Mieke Dons filed 13 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts 2025 (PDF)
When are the next annual accounts of Apotheek Mieke Dons due?
By 30-04-2027, for financial year 2026.Timeline

Companies related to Apotheek Mieke Dons

Go further with this company

How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure